() No effect in 1-hour maximum. Australian 2-cities Lag 01. meta-analysis (). Meta-analysis of 2 cities - Brisbane, Sydney. Low heterogeneity. ICD9: 437; ICD10: I46-I49 Myocardial infarction 15-64 years: No n/a n/a n/a n/a No CRF effect. recommended. 65+ years: No effect. No effect in () Australian 2-cities 1-hour maximum. meta-analysis (). Lag 01. Meta-analysis of 2 cities - Brisbane, Sydney. Moderate to high heterogeneity. lCD9: 410; ICDI0: I21, I22 Respiratory Not assessed in 4 65+ years: 0.5% per 10 ug/m3 n/a n/a Recommended cities study 1.020 (1.005-1.046) () Effect ranges from CRF: For 65+ years () per 50 ug/m3 -5 to +20% risk per age-group, 2.8% 15-64 years: No 10 ppb increase in (1.0-4.7%) per 5.4 0 years: No effect effect. SO2 (24-hour ppb from Australian 1-4 years: No effect () average), with study (). 5-14 years: No Based on APHEA effects observed at effect estimates for 5 levels of 4 ppb, but No CRF 15-64 years: No western European marked increases in recommended for all
() 1-hour maximum. Lag 01. Meta-analysis of 2 cities - Brisbane, Sydney. Low heterogeneity. ICD9: 437; ICD10: I46-I49 No effect in Australian 2-cities meta-analysis (). Myocardial infarction 15-64 years: No effect. 65+ years: No effect. () 1-hour maximum. Lag 01. Meta-analysis of 2 cities - Brisbane, Sydney. Moderate to high heterogeneity. lCD9: 410; ICDI0: I21, I22 n/a n/a n/a n/a No CRF recommended. No effect in Australian 2-cities meta-analysis (). Respiratory Not assessed in 4 cities study () 0 years: No effect 1-4 years: No effect 5-14 years: No effect 15-64 years: No 65+ years: 1.020 (1.005-1.046) per 50 ug/m3 15-64 years: No effect. () Based on APHEA estimates for 5 western European 0.5% per 10 ug/m3 () n/a Effect ranges from -5 to +20% risk per 10 ppb increase in SO2 (24-hour average), with effects observed at levels of 4 ppb, but marked increases in n/a Recommended CRF: For 65+ years age-group, 2.8% (1.0-4.7%) per 5.4 ppb from Australian study (). No CRF recommended for all
health-report.docx